The Halifax Group

Investment decisions are driven by the partnership group, led by founder and Senior Partner David Dupree alongside Partners Scott Plumridge and Chris Cathcart. The firm operates with a consensus-oriented Investment Committee that reviews all potential transactions. Dupree's continuity since the firm's 1999 founding provides long-term institutional memory across economic cycles.

Halifax executes control-oriented buyouts, corporate divestitures, management buyouts, and growth recapitalizations in the lower middle market. The firm typically invests $10 million to $50 million of equity in companies with $5 million to $25 million of EBITDA. Halifax has historically focused on business services, healthcare services, and specialized industrial and distribution businesses across North America.

The firm built a significant portion of its historical deal flow through corporate carve-outs and divestitures — acquiring non-core divisions from large corporations that lack the operational focus to manage those units. This requires deep transitional expertise in separating systems, teams, and contracts, which acts as a barrier to entry and reduces auction competition from generalist private equity firms.

Halifax raises capital from institutional limited partners including university endowments, public and private pension funds, insurance companies, and family offices. The firm has historically maintained a low-profile fundraising posture and does not publicly disclose the composition of its investor base or specific fund sizes.

Halifax can offer co-investment opportunities to select limited partners on a deal-by-deal basis, consistent with middle-market private equity norms. This structure allows larger LPs to deploy additional capital without the administrative burden of a separate fund commitment, though the firm does not publicly detail its co-investment policies.